Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

1.

Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.

Diefenbach CS, Soslow RA, Iasonos A, Linkov I, Hedvat C, Bonham L, Singer J, Barakat RR, Aghajanian C, Dupont J.

Cancer. 2006 Oct 1;107(7):1511-9.

PMID:
16944535
[PubMed - indexed for MEDLINE]
Free Article
2.

Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.

Leitao MM Jr, Boyd J, Hummer A, Olvera N, Arroyo CD, Venkatraman E, Baergen RN, Dizon DS, Barakat RR, Soslow RA.

Am J Surg Pathol. 2004 Feb;28(2):147-59.

PMID:
15043303
[PubMed - indexed for MEDLINE]
3.

Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis.

Niesporek S, Denkert C, Weichert W, Köbel M, Noske A, Sehouli J, Singer JW, Dietel M, Hauptmann S.

Br J Cancer. 2005 May 9;92(9):1729-36.

PMID:
15841084
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.

Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR.

Am J Surg Pathol. 2005 Jun;29(6):707-23.

PMID:
15897738
[PubMed - indexed for MEDLINE]
5.

Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies.

Springett GM, Bonham L, Hummer A, Linkov I, Misra D, Ma C, Pezzoni G, Di Giovine S, Singer J, Kawasaki H, Spriggs D, Soslow R, Dupont J.

Cancer Res. 2005 Oct 15;65(20):9415-25. Erratum in: Cancer Res. 2005 Dec 15;65(24):11785.

PMID:
16230405
[PubMed - indexed for MEDLINE]
Free Article
6.

Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.

Chang SJ, Ryu HS, Chang KH, Yoo SC, Yoon JH.

Acta Obstet Gynecol Scand. 2008;87(4):476-81. doi: 10.1080/00016340801995640.

PMID:
18382877
[PubMed - indexed for MEDLINE]
7.

Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.

Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, O'Brien PM, Li Y.

Gynecol Oncol. 2009 Aug;114(2):265-72. doi: 10.1016/j.ygyno.2009.04.031. Epub 2009 May 17.

PMID:
19450871
[PubMed - indexed for MEDLINE]
8.

Overexpression of mammaglobin B in epithelial ovarian carcinomas.

Tassi RA, Bignotti E, Rossi E, Falchetti M, Donzelli C, Calza S, Ravaggi A, Bandiera E, Pecorelli S, Santin AD.

Gynecol Oncol. 2007 Jun;105(3):578-85. Epub 2007 Mar 6.

PMID:
17343903
[PubMed - indexed for MEDLINE]
9.

[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].

Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.

Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Chinese.

PMID:
17631760
[PubMed - indexed for MEDLINE]
10.

Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.

Luo LY, Katsaros D, Scorilas A, Fracchioli S, Piccinno R, Rigault de la Longrais IA, Howarth DJ, Diamandis EP.

Clin Cancer Res. 2001 Aug;7(8):2372-9.

PMID:
11489815
[PubMed - indexed for MEDLINE]
Free Article
11.

Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.

Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E.

Pathol Res Pract. 2008;204(6):379-87. doi: 10.1016/j.prp.2008.01.011. Epub 2008 Mar 17.

PMID:
18343598
[PubMed - indexed for MEDLINE]
12.

Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.

Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH.

Clin Cancer Res. 2004 Jul 15;10(14):4761-8.

PMID:
15269150
[PubMed - indexed for MEDLINE]
Free Article
13.

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.

Chien J, Fan JB, Bell DA, April C, Klotzle B, Ota T, Lingle WL, Gonzalez Bosquet J, Shridhar V, Hartmann LC.

Gynecol Oncol. 2009 Jul;114(1):3-11. doi: 10.1016/j.ygyno.2009.04.002. Epub 2009 May 1.

PMID:
19410283
[PubMed - indexed for MEDLINE]
14.

[Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer].

Coronado Martín PJ, Fasero Laiz M, García Santos J, Ramírez Mena M, Vidart Aragón JA.

Med Clin (Barc). 2007 Jan 13;128(1):1-6. Spanish.

PMID:
17266884
[PubMed - indexed for MEDLINE]
15.

Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.

Schilder RJ, Sill MW, Lee RB, Shaw TJ, Senterman MK, Klein-Szanto AJ, Miner Z, Vanderhyden BC.

J Clin Oncol. 2008 Jul 10;26(20):3418-25. doi: 10.1200/JCO.2007.14.3420.

PMID:
18612157
[PubMed - indexed for MEDLINE]
16.

Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type.

Yamamoto S, Tsuda H, Honda K, Kita T, Takano M, Tamai S, Inazawa J, Yamada T, Matsubara O.

Mod Pathol. 2007 Dec;20(12):1278-85. Epub 2007 Sep 14.

PMID:
17873890
[PubMed - indexed for MEDLINE]
Free Article
17.

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

Landrum LM, Moore KN, Myers TK, Lanneau GS Jr, McMeekin DS, Walker JL, Gold MA.

Gynecol Oncol. 2009 Feb;112(2):337-41. doi: 10.1016/j.ygyno.2008.10.009. Epub 2008 Nov 28.

PMID:
19041126
[PubMed - indexed for MEDLINE]
18.

Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.

Shan SJ, Scorilas A, Katsaros D, Rigault de la Longrais I, Massobrio M, Diamandis EP.

Clin Chem. 2006 Oct;52(10):1879-86. Epub 2006 Aug 17.

PMID:
16916986
[PubMed - indexed for MEDLINE]
Free Article
19.

Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Christensen IJ, Gayther S, Jacobs IJ, Høgdall CK.

Gynecol Oncol. 2007 Aug;106(2):318-24. Epub 2007 May 31.

PMID:
17540436
[PubMed - indexed for MEDLINE]
20.

Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance.

Wang L, Ma J, Liu F, Yu Q, Chu G, Perkins AC, Li Y.

Gynecol Oncol. 2007 Jun;105(3):695-702. Epub 2007 Mar 21.

PMID:
17368732
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk